Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flow from operating activities:
Net loss	$ (10,242)	$ (96,078)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	6,997	6,211
Non cash lease expense	(41)
Deferred income taxes		(1,356)
Provision for doubtful accounts	981	113
Change in fair value of warrant liabilities	(31,613)	(2,258)
Stock-based compensation expense	11,470	38,077
Change in fair value of contingent consideration	(73,441)	(17,845)
Change in fair value of contingent stock consideration	415
Change in fair value of debt	291
Other, net	(1,432)	3,206
Changes in assets and liabilities:
Accounts receivable	(2,688)	(754)
Inventory	(16,830)	(3,778)
Prepaid expenses and other assets	510	(1,522)
Sale of net operating loss and R&D tax credits		1,356
Accounts payable	297	1,364
Accrued expenses and other liabilities	6,546	3,846
Right-of-use assets and lease liabilities	195
Deferred revenue	294	(8,633)
Net cash used in operating activities	(108,291)	(78,051)
Cash flow from investing activities:
Capital expenditures	(4,457)	(3,900)
Proceeds from promissory note		300
Net cash used in investing activities	(4,457)	(3,600)
Cash flow from financing activities:
Proceeds from short term borrowings - related party		5,000
Payment of short term borrowings - related party		(5,000)
Proceeds from the exercise of stock options	647	223
Proceeds from the exercise of warrants	46,490
Proceeds from PIPE financing	30,000	83,400
Proceeds from the sale of common stock in ATM offering	4,570
Proceeds from short-term debt	39,200
Proceeds from Palantir investment		20,000
Payments of ATM offering costs and commissions	(205)
Payments of PIPE/SPAC related costs	(2,549)	(9,433)
Net cash provided by financing activities	118,153	99,576
Net increase in cash, cash equivalents and restricted cash	5,405	17,925
Cash, cash equivalents and restricted cash at beginning of period	52,076	69,513
Cash, cash equivalents and restricted cash at end of period	57,481	87,438
Supplemental disclosure of cash flow information:
Cash paid for income taxes		11
Supplemental non-cash investing and financing activities:
Property and equipment included in accounts payable and accrued expenses	(1,014)	(1,601)
Conversion of Series A, Series B and Series X preferred stock into common stock		550,113
Cancellation of treasury stock		256
Issuance of common stock as payment for PIPE/merger related costs		10,795
Reclassification of warrant liabilities to equity		96,398
ATM related costs included in accounts payable and accrued expenses	(234)
PIPE related costs included in accrued expenses	(55)
Reclassification of option liabilities to equity	$ 441
Change in PIPE/SPAC related costs captured in accounts payable and accrued expenses		1,103
GX Acquisition Corp.
Cash flow from financing activities:
Cash received on recapitalization		5,386
Supplemental non-cash investing and financing activities:
Non-cash assets acquired from the merger		163
Warrant liability assumed from the merger		$ 59,202